Literature DB >> 2745450

Purification and identification of the lipoprotein-binding proteins from human blood platelet membrane.

E Koller1, F Koller, B R Binder.   

Abstract

As reported previously, homologous plasma lipoproteins specifically bind to the plasma membrane of human blood platelets. The two major lipoprotein-binding membrane glycoproteins were purified to apparent homogeneity and identified by their mobilities in sodium dodecyl sulfate-polyacrylamide gel electrophoresis, both in the nonreduced and reduced state, by specific antibodies against glycoproteins IIb (GPIIb) and IIIa (GPIIIa), respectively, including the alloantibody anti-PlA1 and monoclonal antibodies. Furthermore, lipoprotein binding to intact platelets is also inhibited in a dose-dependent fashion by preincubation of the platelets with antibodies against these glycoproteins. From these experiments it can be concluded that lipoproteins bind to both components of the glycoprotein IIb-IIIa complex in isolated membranes and intact platelets. High density lipoprotein and low density lipoprotein bind to GPIIIa blotted to nitrocellulose in a way that binding of one species interferes with the binding of the other. Addition of fibrinogen significantly inhibits this binding. The specific binding of fibrinogen to GPIIIa is strongly inhibited in the presence of either of the two lipoproteins. LDL and HDL are specifically bound by isolated GPIIb, too. In our blotting experiments fibrinogen shows no binding to this membrane glycoprotein. On the other hand, fibrinogen significantly interferes with the interaction between GPIIb and the lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2745450

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Comparison of iodine-123 low-density lipoprotein (LDL) and indium-111 LDL binding to mononuclear cells of healthy normolipaemic controls and patients with heterozygous familial hypercholesterolaemia.

Authors:  M Banyai; G Lupattelli; S R Li; S Pongratz; Q Yang; P Böck; P Angelberger; I Virgolini
Journal:  Eur J Nucl Med       Date:  1994-07

2.  Transfer of phosphatidylcholine, phosphatidylethanolamine and sphingomyelin from low- and high-density lipoprotein to human platelets.

Authors:  B Engelmann; C Kögl; R Kulschar; B Schaipp
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

3.  Proteolytic susceptibility of platelet low density lipoprotein receptor.

Authors:  J Pedreño; R Fernández
Journal:  Lipids       Date:  1995-10       Impact factor: 1.880

4.  Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways.

Authors:  Katie S Wraith; Simbarashe Magwenzi; Ahmed Aburima; Yichuan Wen; David Leake; Khalid M Naseem
Journal:  Blood       Date:  2013-05-22       Impact factor: 22.113

5.  An interaction map of circulating metabolites, immune gene networks, and their genetic regulation.

Authors:  Artika P Nath; Scott C Ritchie; Sean G Byars; Liam G Fearnley; Aki S Havulinna; Anni Joensuu; Antti J Kangas; Pasi Soininen; Annika Wennerström; Lili Milani; Andres Metspalu; Satu Männistö; Peter Würtz; Johannes Kettunen; Emma Raitoharju; Mika Kähönen; Markus Juonala; Aarno Palotie; Mika Ala-Korpela; Samuli Ripatti; Terho Lehtimäki; Gad Abraham; Olli Raitakari; Veikko Salomaa; Markus Perola; Michael Inouye
Journal:  Genome Biol       Date:  2017-08-01       Impact factor: 13.583

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.